REIV-TOXO Project: Results from a Spanish cohort of congenital toxoplasmosis (2015–2022). The beneficial effects of prenatal treatment on clinical outcomes of infected newborns
While diagnosis based only on neonatal assessment misses a significant number of CT cases, prenatal screening allows treatment to be started during pregnancy, with better clinical outcomes at birth and during follow-up. REIV-TOXO provides valuable information about CT in Spain, highlighting the need for universal maternal screening.
Authors
- Pere Soler‐Palacín (ORCID: https://orcid.org/0000-0002-0346-5570)
- Borja Guarch-Ibáñez (ORCID: https://orcid.org/0000-0002-8601-0191)
- Fernando Baquero‐Artigao (ORCID: https://orcid.org/0000-0002-6903-3826)
- Daniel Blázquez‐Gamero (ORCID: https://orcid.org/0000-0001-6483-8329)
- Isabel Fuentes-Corripio (ORCID: https://orcid.org/0000-0003-3605-6252)
- Marie Antoinette Frick
- Clara Carreras‐Abad (ORCID: https://orcid.org/0000-0002-9068-3233)
Institutions
- Universitat de Girona (ES)
- Hospital Universitario La Paz (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario 12 De Octubre (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Centro Nacional de Microbiologia (ES)
- Hospital Materno-Infantil (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital Universitari de Girona Doctor Josep Trueta (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1371/journal.pntd.0012619
- Citations
- 16
- Primary Topic
- Toxoplasma gondii Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.25
Funders
- Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III